跳至主要内容
临床试验/NCT02225483
NCT02225483已完成不适用

Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function

CancerCare Manitoba2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
2
主要终点
Procoagulant platelet-derived microparticle formation

研究概览

简要总结

The is study will examine whether variation in clinical bleeding frequency and severity among boys with severe Hemophilia A (Factor VIII deficiency) is associated with variations in laboratory measurements of platelet activity.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
3 Years 至 20 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • documented circulating FVIII level of ≤1%
  • age 3 - 20 years
  • may be on primary or secondary prophylaxis
  • granting of informed consent

排除标准

  • measurable inhibitor level at the time of enrollment
  • ingestion of aspirin/supplement known to influence platelet function within 14 days of blood sampling, or ibuprofen within 3 days

结局指标

主要结局

Procoagulant platelet-derived microparticle formation

时间窗: At time of enrollment

Platelet aggregation

时间窗: At time of enrollment

Whole blood platelet aggregation responses

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验